Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence and Booster Study of Boostrix Tdap Vaccine
NCT00489970Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2007
- Primary completion
- Sep 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) in Tetanus, diphtheria, pertussis, sponsored by GSK. Started Jun 2007; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT00489970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489970.